Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5276
CALL
Beazer Homes USA
BZH
$877M
| $120K | ﹤0.01% |
8,500
-45,100
| -84% | -$684K |
|
5277
Capital Bancorp
CBNK
$608M
| $120K | ﹤0.01% |
8,105
+4,073
| +101% | +$57.8K |
|
5278
CALL
Church & Dwight Co
CHD
$23.4B
| $120K | ﹤0.01% |
+1,700
| New | +$121K |
|
5279
CALL
SBA Communications
SBAC
$19.2B
| $120K | ﹤0.01% |
500
-200
| -29% | -$47.4K |
|
|
FFNW
5280
DELISTED
First Financial Northwest, Inc
FFNW
| $120K | ﹤0.01% |
8,084
+4,022
| +99% | +$58.3K |
|
|
OTIC
5281
DELISTED
Otonomy, Inc.
OTIC
| $120K | ﹤0.01% |
31,236
-23
| -0.1% | -$56 |
|
5282
Avalo Therapeutics
AVTX
$965M
| $119K | ﹤0.01% |
8
+4
| +100% | +$42.2K |
|
5283
iShares Russell 2000 Value ETF
IWN
$14.3B
| $119K | ﹤0.01% |
923
-6,864
| -88% | -$849K |
|
|
PRVL
5284
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $119K | ﹤0.01% |
7,564
+3,761
| +99% | +$48K |
|
|
HCR
5285
CALL
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $119K | ﹤0.01% |
135,100
+3,100
| +2% | +$3.27K |
|
5286
Cytosorbents Corp
CTSO
$22.7M
| $118K | ﹤0.01% |
30,621
+15,453
| +102% | +$67.4K |
|
5287
PUT
Lithia Motors
LAD
$8.47B
| $118K | ﹤0.01% |
800
+500
| +167% | +$75.1K |
|
|
OTRK
5288
DELISTED
Ontrak
OTRK
| $118K | ﹤0.01% |
80
+37
| +86% | +$51.1K |
|
5289
PUT
Texas Roadhouse
TXRH
$13.5B
| $118K | ﹤0.01% |
2,100
-3,800
| -64% | -$209K |
|
|
ENZ
5290
DELISTED
Enzo Biochem, Inc.
ENZ
| $118K | ﹤0.01% |
44,979
+22,067
| +96% | +$65.9K |
|
5291
PUT
Air Products & Chemicals
APD
$65.7B
| $117K | ﹤0.01% |
500
-500
| -50% | -$113K |
|
5292
PUT
Banc of California
BANC
$3.03B
| $117K | ﹤0.01% |
6,800
+5,800
| +580% | +$87.6K |
|
5293
BioLife Solutions
BLFS
$1.53B
| $117K | ﹤0.01% |
7,260
+401
| +6% | +$6.52K |
|
5294
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$741M
| $117K | ﹤0.01% |
2,667
| – | – |
|
5295
CALL
Myriad Genetics
MYGN
$270M
| $117K | ﹤0.01% |
4,300
-4,200
| -49% | -$116K |
|
5296
Saga Communications
SGA
$57M
| $117K | ﹤0.01% |
3,875
+3,866
| +42,956% | +$117K |
|
|
XNET
5297
Xunlei
XNET
$340M
| $117K | ﹤0.01% |
23,900
-169,604
| -88% | -$736K |
|
|
SHSP
5298
DELISTED
SharpSpring, Inc.
SHSP
| $117K | ﹤0.01% |
10,224
+5,184
| +103% | +$52.8K |
|
5299
CALL
Canadian Imperial Bank of Commerce
CM
$108B
| $116K | ﹤0.01% |
2,800
-34,800
| -93% | -$1.47M |
|
5300
PUT
Ecolab
ECL
$78.1B
| $116K | ﹤0.01% |
600
-5,000
| -89% | -$949K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.